The Latest Cardiac and Vascular News
TORONTO–(BUSINESS WIRE)–Conavi Medical Inc. (www.conavi.com), a leader of hybrid imaging guidance for common minimally invasive heart procedures, has entered into agreements for over $20 million in funding to support commercialization and growth as it prepares its innovative Novasight Hybrid® System for market. The company aims to raise an additional $10 million […]
€6 million of further funds raised in addition to the €15 million in June Clinical trials expected in 2022 BORDEAUX, France–(BUSINESS WIRE)–FineHeart S.A, a preclinical medical device company that has developed the ICOMS FLOWMAKER®, an Implantable Cardiac Output Management System designed to address the unmet need of patients suffering from […]
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA), a global leader in health technology, today announced that it has signed an agreement to acquire Vesper Medical Inc., a US-based medical technology company that develops minimally-invasive peripheral vascular devices. Vesper Medical will further expand Philips’ portfolio of diagnostic and therapeutic devices […]
Presents update on novel neurovascular medical device at B.R.A.I.N. Conference PRAIRIE VILLAGE, Kan., Dec. 14, 2021 /PRNewswire/ — Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, today announced that distinguished neurovascular and peripheral vascular interventional radiologist, Blaise W. Baxter, MD, FRCPC, FSNIC, has […]
GUILFORD, Conn., Dec. 13, 2021 /PRNewswire/ — Hyperfine Inc., creator of Swoop®, the first FDA-cleared portable magnetic resonance imaging™ (MRI) device, today announced the Board of Directors that will serve subsequent to the closing of the previously announced business combination between Hyperfine, Liminal Sciences, Inc., and HealthCor Catalio Acquisition Corp, subject to […]
DUBLIN, Dec. 10, 2021 /PRNewswire/ — The board of directors of Medtronic plc (NYSE:MDT) on Thursday, December 9, 2021, approved the fiscal year 2022 third quarter cash dividend of $0.63 per ordinary share, representing a 9 percent increase over the prior year. This quarterly declaration is consistent with the dividend announcement made by the company in May […]
Globally recognized interventional cardiologist is the latest addition to a growing leadership team MIAMI LAKES, Fla., Dec. 9, 2021 /PRNewswire/ — Cordis, a global cardiovascular technology company, today announced George Adams, MD, MHS, MBA, FACC, FSCAI as Chief Medical Officer, furthering the organization’s mission to differentiate itself as a technological leader and value-based […]
PITTSBURGH, Dec. 9, 2021 /PRNewswire/ — GPVA announced it had opened two new sites to serve patients in the Pittsburgh region at 1000 Park Place Drive, Suite 201 in Washington, PA and at 27 North Thompson Lane, Suite C, in North Huntingdon, PA. For over two decades, the board-certified physicians and staff at GPVA have been a leading provider […]
BOSTON, Dec. 09, 2021 (GLOBE NEWSWIRE) — Balt, an innovative neurovascular company focused on developing, designing, and manufacturing solutions for treating complex, life-threatening conditions, including stroke, aneurysms, and arteriovenous malformations, today announced the appointment of Jeffrey Sachs as the Company’s Chief Legal & Compliance Officer. Jeffrey Sachs joins the Balt […]
Renova Therapeutics Inc, a leader in the development of gene therapies for cardiovascular diseases and diabetes, announced the appointment of Dr. Vijay Mahant to the position of CEO, effective as of Sept. 16, 2021. CARLSBAD, Calif., Dec. 09, 2021 (GLOBE NEWSWIRE) — Dr. Mahant brings a wealth of knowledge and […]
